Provided by Tiger Trade Technology Pte. Ltd.

Gossamer Bio Inc.

0.3465
-0.0283-7.55%
Post-market: 0.35890.0124+3.58%19:03 EDT
Volume:9.49M
Turnover:3.39M
Market Cap:81.32M
PE:-0.46
High:0.3800
Open:0.3600
Low:0.3440
Close:0.3748
52wk High:3.87
52wk Low:0.3213
Shares:234.70M
Float Shares:211.00M
Volume Ratio:0.45
T/O Rate:4.50%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7455
EPS(LYR):-0.7455
ROE:-783.37%
ROA:-41.86%
PB:-0.66
PE(LYR):-0.46

Loading ...

NASDAQ TRADE HALT HALT NEWS PENDING AT 07:58 AM

Reuters
·
Feb 23

Gossamer Bio (GOSS) Receives a Buy from Barclays

TIPRANKS
·
Feb 10

Gossamer Bio Initiated at Overweight by Barclays

Dow Jones
·
Jan 28

Barclays Initiates Coverage on Gossamer Bio With Overweight Rating, $9 Price Target

MT Newswires Live
·
Jan 28

Gossamer Bio Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Dow Jones
·
Jan 22

Gossamer Bio Grants Stock Options to New Employees Under 2023 Inducement Plan

Reuters
·
Jan 09

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Jan 09

Gossamer Bio Currently Down Eight Consecutive Days, on Pace for Longest Losing Streak Since November 2024 -- Data Talk

Dow Jones
·
Jan 08

BRIEF-Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Dec 10, 2025

Gossamer Bio Grants Stock Options to New Employee Under Inducement Plan

Reuters
·
Dec 10, 2025

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Nov 20, 2025

Stock Track | Gossamer Bio Soars 5.30% Pre-Market as Oppenheimer Raises Price Target

Stock Track
·
Nov 10, 2025

BRIEF-Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Nov 08, 2025

Gossamer Bio Grants Stock Options to New Employees Under 2023 Inducement Plan

Reuters
·
Nov 08, 2025

Gossamer Bio Inc. to Present at Guggenheim Securities Healthcare Innovation Conference

Reuters
·
Nov 07, 2025

Gossamer Bio's Q3 net loss widens to $48.2 mln

Reuters
·
Nov 06, 2025

BRIEF-Gossamer Bio Q3 EPS USD -0.21

Reuters
·
Nov 06, 2025

Gossamer Bio Inc expected to post a loss of 19 cents a share - Earnings Preview

Reuters
·
Nov 04, 2025

EXPLAINER-How companies are steering IPO plans amid US government shutdown

Reuters
·
Oct 07, 2025

Wedbush Adjusts Gossamer Bio Price Target to $6 From $5, Maintains Outperform Rating

MT Newswires Live
·
Sep 25, 2025